Serotonin and the Modulation of Brain Development
血清素和大脑发育的调节
基本信息
- 批准号:7999281
- 负责人:
- 金额:$ 34.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-02-01 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdolescentAdultAffectAffectiveAgeAge of OnsetAlcoholismAllelesAmygdaloid structureAnalysis of VarianceAnimalsAnorexia NervosaAnteriorAntidepressive AgentsAntisocial Personality DisorderAnxietyAnxiety DisordersAreaAutistic DisorderBehaviorBehavioralBehavioral ParadigmBirth RateBrainBrain regionButyric AcidsCellsCitalopramClomipramineCodeCollaborationsCorpus striatum structureDataDendritesDesipramineDevelopmentDiseaseDoctor of PhilosophyDorsalDoxycyclineDrug KineticsElectrodesElectrophysiology (science)EmbryoEmotionalEtiologyEventExhibitsExposure toExtinction (Psychology)FemaleFluoxetineFunctional disorderGene ExpressionGenesGeneticGenetic VariationGenotypeGlutamate ReceptorGoalsGolgi ApparatusGrowthGrowth FactorHeterozygoteHippocampus (Brain)Hydroxyindoleacetic AcidInvestigationKnock-outKnowledgeLaboratoriesLeadLearningLengthLifeLinkMapsMeasurementMeasuresMediatingMental DepressionMental disordersMethaqualoneMicroelectrodesMolecular TargetMonoamine Oxidase AMonoamine Oxidase InhibitorsMood DisordersMorphologyMusNeuraxisNeuroanatomyNeurotransmittersObsessive-Compulsive DisorderOccupationsPathway interactionsPatternPerinatalPerinatal ExposurePharmacodynamicsPhenotypePhysiologicalPhysiologyPlayPolymerase Chain ReactionPredispositionPregnancyPrimatesPrincipal InvestigatorPromoter RegionsPublicationsPublished CommentPublishingRadialRepressionResearch PersonnelResponse to stimulus physiologyRiskRodentRoleScanningSelective Serotonin Reuptake InhibitorSerotoninShort-Term MemorySignal TransductionSpecific qualifier valueSpecificityStaining methodStainsStressStructureSuggestionSurvival RateSwimmingSystemTestingTetracyclinesTherapeuticTimeTrainingTrans-ActivatorsUnited States National Institutes of HealthVariantWorkWritingarmaxonal guidancebasebrain morphologycarbon fibercingulate cortexconditioned fearcritical periodearly childhoodearly life exposureexperiencegamma-Aminobutyric Acidgenetic manipulationgenetic variantin vivoinhibitor/antagonistinterestknowledge of resultsmalemorris water mazeneuropathologyneuropsychiatrynoradrenaline transporteroffspringpostnatalprogramspromoterresearch studyresponseserotonin transportertool
项目摘要
DESCRIPTION (provided by applicant): The serotonin transporter (SERT) is a critical regulator of emotional function that acts both during brain development as a growth modulator and as a neurotransmitter in the more mature brain. It is the primary molecular target for many antidepressants, especially the serotonin selective reuptake inhibitors (SSRIs), which are used as a first- line treatment for a number of psychiatric conditions. SSRIs increase serotonergic tone, and this effect is thought to mediate their therapeutic actions. Paradoxically, genetically reduced SERT expression increases the risk for affective- and anxiety-like behaviors in adult humans, primates, and rodents. The abnormal behaviors of genetically-impaired SERT mice are recapitulated by early life exposure to SERT-blocking agents such as fluoxetine, clomipramine, and citalopram. These findings indicate a critical role of serotonin in the maturation of brain systems that modulate emotional function in the adult and suggest a developmental mechanism to explain how low-expressing SERT promoter alleles increase vulnerability to psychiatric disorders. Moreover, these findings suggest that fetal exposure to SSRIs during pregnancy or early childhood may increase the risk of psychiatric disorders later in life. In this application, we propose several experiments that increase our understanding of the role serotonin plays in modulating brain development. We examine "critical periods" of development that are sensitive to SERT inhibition. We define the abnormalities of brain structure, connectivity, and physiology that may underlie the adult abnormalities. We also determine the developmental trajectory of behavioral, anatomical, and physiological abnormalities that arise from brief, early exposure to SERT inhibitors. The resulting knowledge obtained by these studies should lead to a better understanding of how serotonin functions during brain development and help inform the underlying pathophysiology of affective and anxiety disorders that may arise due to developmental perturbations in SERT function. Changes in serotonin may affect the way the brain wires itself together during early life. The goal of this proposal is to understand how inhibition of the serotonin transporter affects brain development and behavior. The results have implications for the use of antidepressants during pregnancy and for understanding how certain gene variants predispose to depression and anxiety disorders.
描述(由申请人提供):5-羟色胺转运蛋白(SERT)是情绪功能的关键调节剂,在大脑发育过程中作为生长调节剂和更成熟的大脑中的神经递质起作用。它是许多抗抑郁药的主要分子靶标,尤其是5-羟色胺选择性再摄取抑制剂(SSRIS),用于多种精神疾病的第一线治疗。 SSRI会增加血清素能的语调,这种作用被认为可以介导他们的治疗作用。矛盾的是,遗传降低的SERT表达增加了成年人,灵长类动物和啮齿动物中情感和焦虑样行为的风险。遗传受损的SERT小鼠的异常行为通过早期寿命暴露于Sert阻断药(例如氟西汀,氯米帕明和Citalopram)概括。这些发现表明5-羟色胺在调节成年人情绪功能的大脑系统成熟中的关键作用,并提出了一种发展机制来解释低表达SERT启动子等位基因如何增加对精神疾病的脆弱性。此外,这些发现表明,胎儿在怀孕或幼儿期间暴露于SSRIS可能会增加生命后期精神疾病的风险。在此应用中,我们提出了几项实验,以增加对5-羟色胺在调节大脑发育中所起的作用的理解。我们检查了对SERT抑制敏感的发展的“关键时期”。我们定义了可能是成人异常的基础的大脑结构,连通性和生理学的异常。我们还确定了由短暂的早期暴露于SERT抑制剂引起的行为,解剖和生理异常的发育轨迹。这些研究获得的最终知识应更好地理解脑部发育过程中的血清素功能,并有助于告知由于Sert功能中发育扰动而可能引起的情感和焦虑症的潜在病理生理学。 5-羟色胺的变化可能会影响大脑在早期的启动方式。该提案的目的是了解抑制5-羟色胺转运蛋白如何影响大脑发育和行为。结果对怀孕期间抗抑郁药的使用有影响,并了解某些基因变异如何使抑郁症和焦虑症易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAY A GINGRICH其他文献
JAY A GINGRICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAY A GINGRICH', 18)}}的其他基金
Serotonergic modulation of claustro-cortical circuits
幽闭皮质回路的血清素调节
- 批准号:
8726489 - 财政年份:2013
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic modulation of claustro-cortical circuits
幽闭皮质回路的血清素调节
- 批准号:
8584120 - 财政年份:2013
- 资助金额:
$ 34.93万 - 项目类别:
Project 4: Serotonin-mediated genetic and pharmacologic influences on developing
项目 4:血清素介导的遗传和药理学对发育的影响
- 批准号:
8059843 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
- 批准号:
8478200 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
- 批准号:
7939339 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
- 批准号:
8661053 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
- 批准号:
8269763 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonergic Modulation of Brain Development: Genetic and Pharmacologic Influenc
大脑发育的血清素调节:遗传和药理影响
- 批准号:
8135993 - 财政年份:2010
- 资助金额:
$ 34.93万 - 项目类别:
Serotonin and the Modulation of Brain Development
血清素和大脑发育的调节
- 批准号:
8197718 - 财政年份:2008
- 资助金额:
$ 34.93万 - 项目类别:
相似国自然基金
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
大气污染物对青少年心理健康的影响机制研究
- 批准号:42377437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
- 批准号:32300894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别: